uuid stringlengths 4 8 | template_uuid stringclasses 40
values | question stringlengths 13 193 | answer stringlengths 29 2.2k | benchmark_query stringlengths 133 622 | execution_results stringlengths 2 1.14M | query_type stringclasses 2
values | sql_category stringclasses 26
values | bio_category stringclasses 14
values |
|---|---|---|---|---|---|---|---|---|
Q4.417 | Q4 | What drugs target the gene EPHB2? | The drug that targets EPHB2 is Vandetanib. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%EPHB2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1936', 'drugName': 'Vandetanib', 'newLinkedTargets_string': 'TEK (ENSG00000120156), ERBB2 (ENSG00000141736), EGFR (ENSG00000146648), ERBB4 (ENSG00000178568), ERBB3 (ENSG00000065361), EPHA2 (ENSG00000142627), EPHB2 (ENSG00000133216), EPHA5 (ENSG00000145242), EPHA4 (ENSG00000116106), EPHA8 (... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.851 | Q4 | What drugs target the gene MAP3K11? | There are no approved drugs targeting MAP3K11, but the drug Cep-1347, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%MAP3K11 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6091', 'drugName': 'Cep-1347', 'newLinkedTargets_string': 'MAP3K13 (ENSG00000073803), MAP3K12 (ENSG00000139625), MAP3K10 (ENSG00000130758), MAP3K9 (ENSG00000006432), MAP3K11 (ENSG00000173327)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 3}, {'UUID': 'DrugGeneTargets_v2_6088', 'drugN... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.463 | Q4 | What drugs target the gene FGF23? | The drug that targets FGF23 is Burosumab. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%FGF23 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4495', 'drugName': 'Burosumab', 'newLinkedTargets_string': 'FGF23 (ENSG00000118972)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.509 | Q4 | What drugs target the gene GART? | The drugs that target GART are Pemetrexed Tromethamine, Pemetrexed Disodium, and Pemetrexed. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%GART %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4616', 'drugName': 'Pemetrexed', 'newLinkedTargets_string': 'TYMS (ENSG00000176890), DHFR (ENSG00000228716), GART (ENSG00000159131)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_4615', 'drugName': 'Pemetrexed', 'newLinkedTargets_string': 'TYMS (ENSG000... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1182 | Q4 | What drugs target the gene PSMD3? | The drugs that target PSMD3 are Bortezomib, Carfilzomib, Ixazomib, and Ixazomib Citrate. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PSMD3 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_559', 'drugName': 'Bortezomib', 'newLinkedTargets_string': 'PSMD1 (ENSG00000173692), PSMB2 (ENSG00000126067), PSMB1 (ENSG00000008018), PSMB5 (ENSG00000100804), PSMB8 (ENSG00000204264), PSMB9 (ENSG00000240065), PSMB6 (ENSG00000142507), PSMD14 (ENSG00000115233), PSMA1 (ENSG00000129084), PSMA... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.841 | Q4 | What drugs target the gene MADCAM1? | There are no approved drugs targeting MADCAM1, but the drug Ontamalimab, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%MADCAM1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4678', 'drugName': 'Ontamalimab', 'newLinkedTargets_string': 'MADCAM1 (ENSG00000099866)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 3}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.860 | Q4 | What drugs target the gene MAPK14? | There are no FDA approved drugs targeting the gene MAPK14. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Tak-715, Vx-702, Losmapimod, Ly-3007113, Arry-797, Semapimod, Talmapimod, Azd-6703, Bms-582949, Doramapimod, Ta-5493, Scio-323, Ro-3201195, Ave-994... | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%MAPK14 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_182', 'drugName': 'Losmapimod', 'newLinkedTargets_string': 'MAPK11 (ENSG00000185386), MAPK14 (ENSG00000112062)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 3}, {'UUID': 'DrugGeneTargets_v2_319', 'drugName': 'Arry-797', 'newLinkedTargets_string': 'MAPK14 (ENSG00000112062)', 'drugIsAp... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.235 | Q4 | What drugs target the gene CDK14? | There are no FDA approved drugs targeting the gene CDK14. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Roniciclib, Pha-793887, Azd-5438, and At-7519. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%CDK14 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1429', 'drugName': 'Roniciclib', 'newLinkedTargets_string': 'CDK1 (ENSG00000170312), CDK4 (ENSG00000135446), CDK2 (ENSG00000123374), CDK5 (ENSG00000164885), CDK6 (ENSG00000105810), CDK7 (ENSG00000134058), CDK3 (ENSG00000250506), CDK16 (ENSG00000102225), CDK18 (ENSG00000117266), CDK8 (ENSG0... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1486 | Q4 | What drugs target the gene TRPV3? | There are no approved drugs targeting TRPV3, but the drug Grc-15300, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%TRPV3 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4111', 'drugName': 'Grc-15300', 'newLinkedTargets_string': 'TRPV3 (ENSG00000167723)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.198 | Q4 | What drugs target the gene CD14? | There are no FDA approved drugs targeting the gene CD14. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Ic14 and Vb-201. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%CD14 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1398', 'drugName': 'Ic14', 'newLinkedTargets_string': 'CD14 (ENSG00000170458)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_5798', 'drugName': 'Vb-201', 'newLinkedTargets_string': 'TLR2 (ENSG00000137462), CD14 (ENSG00000170458)', 'drugIsApproved': Fal... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.757 | Q4 | What drugs target the gene KCNH3? | The drugs that target KCNH3 are Dalfampridine, Guanidine, Amifampridine Phosphate, Guanidine Hydrochloride, and Amifampridine. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%KCNH3 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5118', 'drugName': 'Guanidine Hydrochloride', 'newLinkedTargets_string': 'KCNQ1 (ENSG00000053918), KCND3 (ENSG00000171385), KCNH2 (ENSG00000055118), KCNA2 (ENSG00000177301), KCNA1 (ENSG00000111262), KCNQ2 (ENSG00000075043), KCNQ3 (ENSG00000184156), KCNA7 (ENSG00000104848), KCNQ5 (ENSG00000... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1292 | Q4 | What drugs target the gene RPS27? | The drug that targets RPS27 is Ataluren. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%RPS27 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3776', 'drugName': 'Ataluren', 'newLinkedTargets_string': 'RPSA (ENSG00000168028), RPS27 (ENSG00000177954), RPS6 (ENSG00000137154), RPS2 (ENSG00000140988), RPS3 (ENSG00000149273), RPS3A (ENSG00000145425), RPS4X (ENSG00000198034), RPS4Y1 (ENSG00000129824), RPS5 (ENSG00000083845), RPS7 (ENSG... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.83 | Q4 | What drugs target the gene ATP1A4? | The drugs that target ATP1A4 are Acetyldigitoxin, Deslanoside, Digoxin, Lanatoside C, and Digitoxin. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%ATP1A4 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2499', 'drugName': 'Digoxin', 'newLinkedTargets_string': 'ATP1A1 (ENSG00000163399), ATP1B2 (ENSG00000129244), ATP1B1 (ENSG00000143153), ATP1A2 (ENSG00000018625), ATP1B3 (ENSG00000069849), ATP1A3 (ENSG00000105409), ATP1A4 (ENSG00000132681), FXYD2 (ENSG00000137731)', 'drugIsApproved': True, ... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1440 | Q4 | What drugs target the gene TMPRSS6? | There are no approved drugs targeting TMPRSS6, but the drug Sapablursen, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%TMPRSS6 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5289', 'drugName': 'Sapablursen', 'newLinkedTargets_string': 'TMPRSS6 (ENSG00000187045)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.878 | Q4 | What drugs target the gene MERTK? | There are no approved drugs targeting MERTK, but the drug Ningetinib, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%MERTK %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2975', 'drugName': 'Ningetinib', 'newLinkedTargets_string': 'AXL (ENSG00000167601), MET (ENSG00000105976), FLT3 (ENSG00000122025), KDR (ENSG00000128052), MERTK (ENSG00000153208)', 'drugIsApproved': False, 'maxClinicalTrialPhase': -1}, {'UUID': 'DrugGeneTargets_v2_2972', 'drugName': 'Ninget... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1184 | Q4 | What drugs target the gene PSMD6? | The drugs that target PSMD6 are Bortezomib, Carfilzomib, Ixazomib, and Ixazomib Citrate. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PSMD6 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_559', 'drugName': 'Bortezomib', 'newLinkedTargets_string': 'PSMD1 (ENSG00000173692), PSMB2 (ENSG00000126067), PSMB1 (ENSG00000008018), PSMB5 (ENSG00000100804), PSMB8 (ENSG00000204264), PSMB9 (ENSG00000240065), PSMB6 (ENSG00000142507), PSMD14 (ENSG00000115233), PSMA1 (ENSG00000129084), PSMA... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.113 | Q4 | What drugs target the gene BIRC2? | There are no approved drugs targeting BIRC2, but the drug Birinapant, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%BIRC2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_267', 'drugName': 'Birinapant', 'newLinkedTargets_string': 'BIRC3 (ENSG00000023445), BIRC2 (ENSG00000110330)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1309 | Q4 | What drugs target the gene RPS8? | The drug that targets RPS8 is Ataluren. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%RPS8 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3776', 'drugName': 'Ataluren', 'newLinkedTargets_string': 'RPSA (ENSG00000168028), RPS27 (ENSG00000177954), RPS6 (ENSG00000137154), RPS2 (ENSG00000140988), RPS3 (ENSG00000149273), RPS3A (ENSG00000145425), RPS4X (ENSG00000198034), RPS4Y1 (ENSG00000129824), RPS5 (ENSG00000083845), RPS7 (ENSG... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.807 | Q4 | What drugs target the gene LAMB1? | The drug that targets LAMB1 is Ocriplasmin. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%LAMB1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5818', 'drugName': 'Ocriplasmin', 'newLinkedTargets_string': 'FN1 (ENSG00000115414), COL1A2 (ENSG00000164692), COL1A1 (ENSG00000108821), COL2A1 (ENSG00000139219), COL3A1 (ENSG00000168542), COL4A1 (ENSG00000187498), COL5A1 (ENSG00000130635), COL6A1 (ENSG00000142156), COL11A1 (ENSG0000006071... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1013 | Q4 | What drugs target the gene NTRK1? | The drugs that target NTRK1 are Regorafenib, Larotrectinib, Entrectinib, Cenegermin, and Larotrectinib Sulfate. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%NTRK1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_808', 'drugName': 'Regorafenib', 'newLinkedTargets_string': 'EPHA2 (ENSG00000142627), TEK (ENSG00000120156), MAPK11 (ENSG00000185386), RAF1 (ENSG00000132155), FRK (ENSG00000111816), PDGFRB (ENSG00000113721), PDGFRA (ENSG00000134853), KIT (ENSG00000157404), FGFR1 (ENSG00000077782), DDR2 (EN... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.779 | Q4 | What drugs target the gene KCNQ5? | The drugs that target KCNQ5 are Dalfampridine, Guanidine, Amifampridine Phosphate, Ezogabine, Guanidine Hydrochloride, and Amifampridine. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%KCNQ5 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3665', 'drugName': 'Ezogabine', 'newLinkedTargets_string': 'KCNQ1 (ENSG00000053918), KCNQ2 (ENSG00000075043), KCNQ3 (ENSG00000184156), KCNQ5 (ENSG00000185760), KCNQ4 (ENSG00000117013)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_5420', 'drugName': 'Am... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1298 | Q4 | What drugs target the gene RPS4X? | The drug that targets RPS4X is Ataluren. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%RPS4X %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3776', 'drugName': 'Ataluren', 'newLinkedTargets_string': 'RPSA (ENSG00000168028), RPS27 (ENSG00000177954), RPS6 (ENSG00000137154), RPS2 (ENSG00000140988), RPS3 (ENSG00000149273), RPS3A (ENSG00000145425), RPS4X (ENSG00000198034), RPS4Y1 (ENSG00000129824), RPS5 (ENSG00000083845), RPS7 (ENSG... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.725 | Q4 | What drugs target the gene ITGB5? | There are no FDA approved drugs targeting the gene ITGB5. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Abituzumab, Intetumumab, and Cilengitide. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%ITGB5 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5584', 'drugName': 'Cilengitide', 'newLinkedTargets_string': 'ITGB3 (ENSG00000259207), ITGAV (ENSG00000138448), ITGB5 (ENSG00000082781)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 3}, {'UUID': 'DrugGeneTargets_v2_5585', 'drugName': 'Cilengitide', 'newLinkedTargets_string': 'ITGB3 (... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.312 | Q4 | What drugs target the gene CPT1B? | The drugs that target CPT1B are Perhexiline and Perhexiline Maleate. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%CPT1B %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1726', 'drugName': 'Perhexiline Maleate', 'newLinkedTargets_string': 'MTOR (ENSG00000198793), CPT2 (ENSG00000157184), CPT1B (ENSG00000205560)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_919', 'drugName': 'Perhexiline', 'newLinkedTargets_string': 'MTO... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1366 | Q4 | What drugs target the gene SLC22A6? | The drug that targets SLC22A6 is Probenecid. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%SLC22A6 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1876', 'drugName': 'Probenecid', 'newLinkedTargets_string': 'SLC22A8 (ENSG00000149452), SLC22A6 (ENSG00000197901), SLC22A11 (ENSG00000168065)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_1877', 'drugName': 'Probenecid', 'newLinkedTargets_string': 'SLC... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.951 | Q4 | What drugs target the gene NDUFAF2? | The drugs that target NDUFAF2 are Metformin and Metformin Hydrochloride. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%NDUFAF2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1888', 'drugName': 'Metformin Hydrochloride', 'newLinkedTargets_string': 'GPD2 (ENSG00000115159), MT-ND6 (ENSG00000198695), NDUFA10 (ENSG00000130414), NDUFS8 (ENSG00000110717), MT-ND4L (ENSG00000212907), NDUFA6 (ENSG00000184983), MT-ND1 (ENSG00000198888), NDUFB6 (ENSG00000165264), NDUFA4 (... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.638 | Q4 | What drugs target the gene IDH2? | The drugs that target IDH2 are Enasidenib and Enasidenib Mesylate. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%IDH2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2059', 'drugName': 'Enasidenib', 'newLinkedTargets_string': 'IDH2 (ENSG00000182054)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_5694', 'drugName': 'Enasidenib Mesylate', 'newLinkedTargets_string': 'IDH2 (ENSG00000182054)', 'drugIsApproved': True, 'ma... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1347 | Q4 | What drugs target the gene SELP? | The drug that targets SELP is Crizanlizumab. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%SELP %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4256', 'drugName': 'Crizanlizumab', 'newLinkedTargets_string': 'SELP (ENSG00000174175)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_2473', 'drugName': 'Rivipansel', 'newLinkedTargets_string': 'SELE (ENSG00000007908), SELP (ENSG00000174175), SELL (ENSG... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1139 | Q4 | What drugs target the gene PRKCH? | The drug that targets PRKCH is Midostaurin. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PRKCH %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5666', 'drugName': 'Midostaurin', 'newLinkedTargets_string': 'KIT (ENSG00000157404), KDR (ENSG00000128052), PDGFRB (ENSG00000113721), PDGFRA (ENSG00000134853), FLT3 (ENSG00000122025), PRKD3 (ENSG00000115825), PRKCI (ENSG00000163558), PRKCA (ENSG00000154229), PRKCG (ENSG00000126583), PRKCD ... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1335 | Q4 | What drugs target the gene SCN4A? | The drugs that target SCN4A are Propoxycaine, Orphenadrine, Indecainide, Quinidine Polygalacturonate, Fosphenytoin Sodium, Prilocaine Hydrochloride, Zonisamide, Mexiletine, Hexylcaine Hydrochloride, Fosphenytoin, Phenazopyridine Hydrochloride, Primidone, Phenytoin Sodium, Propafenone, Topiramate, Chloroprocaine, Etidoc... | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%SCN4A %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6341', 'drugName': 'Ranolazine', 'newLinkedTargets_string': 'SCN4A (ENSG00000007314), SCN5A (ENSG00000183873)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_5933', 'drugName': 'Lidocaine', 'newLinkedTargets_string': 'SCN1A (ENSG00000144285), SCN5A (ENSG... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.367 | Q4 | What drugs target the gene DNMT1? | The drugs that target DNMT1 are Decitabine and Azacitidine. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%DNMT1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4132', 'drugName': 'Azacitidine', 'newLinkedTargets_string': 'DNMT1 (ENSG00000130816), DNMT3A (ENSG00000119772)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_4131', 'drugName': 'Azacitidine', 'newLinkedTargets_string': 'DNMT1 (ENSG00000130816), DNMT3A ... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1526 | Q4 | What drugs target the gene VEGFB? | There are no approved drugs targeting VEGFB, but the drug Conbercept, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%VEGFB %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4611', 'drugName': 'Conbercept', 'newLinkedTargets_string': 'VEGFA (ENSG00000112715), VEGFC (ENSG00000150630), PGF (ENSG00000119630), VEGFB (ENSG00000173511)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 3}, {'UUID': 'DrugGeneTargets_v2_4610', 'drugName': 'Conbercept', 'newLinkedTarg... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1049 | Q4 | What drugs target the gene PDE4B? | The drugs that target PDE4B are Flavoxate, Theophylline Sodium Glycinate, Flavoxate Hydrochloride, Apremilast, Dyphylline, Theophylline Glycinate, Oxtriphylline, Pentoxifylline, Theophylline, Amlexanox, Roflumilast, Aminophylline, Crisaborole, and Dipyridamole. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PDE4B %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3798', 'drugName': 'Oxtriphylline', 'newLinkedTargets_string': 'PDE3A (ENSG00000172572), PDE3B (ENSG00000152270), PDE4A (ENSG00000065989), PDE4D (ENSG00000113448), PDE4B (ENSG00000184588), PDE4C (ENSG00000105650), ADORA1 (ENSG00000163485), ADORA2B (ENSG00000170425), ADORA3 (ENSG00000282608... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.435 | Q4 | What drugs target the gene F11? | The drug that targets F11 is Human C1-Esterase Inhibitor. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%F11 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2063', 'drugName': 'Human C1-Esterase Inhibitor', 'newLinkedTargets_string': 'C1S (ENSG00000182326), F11 (ENSG00000088926), KLKB1 (ENSG00000164344), F12 (ENSG00000131187)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_2065', 'drugName': 'Human C1-Estera... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1101 | Q4 | What drugs target the gene POLA2? | The drugs that target POLA2 are Gemcitabine Hydrochloride, Gemcitabine, Clofarabine, Fludarabine Phosphate, and Cytarabine. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%POLA2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4', 'drugName': 'Gemcitabine Hydrochloride', 'newLinkedTargets_string': 'POLA1 (ENSG00000101868), POLD4 (ENSG00000175482), POLD3 (ENSG00000077514), POLD1 (ENSG00000062822), POLD2 (ENSG00000106628), POLE (ENSG00000177084), POLA2 (ENSG00000014138), PRIM1 (ENSG00000198056), PRIM2 (ENSG0000014... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1517 | Q4 | What drugs target the gene TYRP1? | There are no approved drugs targeting TYRP1, but the drug Flanvotumab, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%TYRP1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4277', 'drugName': 'Flanvotumab', 'newLinkedTargets_string': 'TYRP1 (ENSG00000107165)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 1}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1099 | Q4 | What drugs target the gene PNP? | There are no FDA approved drugs targeting the gene PNP. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Forodesine, Ulodesine, and Forodesine Hydrochloride. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PNP %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5299', 'drugName': 'Ulodesine', 'newLinkedTargets_string': 'PNP (ENSG00000198805)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_5700', 'drugName': 'Forodesine Hydrochloride', 'newLinkedTargets_string': 'PNP (ENSG00000198805)', 'drugIsApproved': False,... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.455 | Q4 | What drugs target the gene FDFT1? | There are no approved drugs targeting FDFT1, but the drug Lapaquistat Acetate, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%FDFT1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3079', 'drugName': 'Lapaquistat Acetate', 'newLinkedTargets_string': 'FDFT1 (ENSG00000079459)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 3}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1490 | Q4 | What drugs target the gene TSLP? | The drug that targets TSLP is Tezepelumab. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%TSLP %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3491', 'drugName': 'Tezepelumab', 'newLinkedTargets_string': 'TSLP (ENSG00000145777)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_89', 'drugName': 'Amg-157', 'newLinkedTargets_string': 'TSLP (ENSG00000145777)', 'drugIsApproved': False, 'maxClinicalTri... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1476 | Q4 | What drugs target the gene TRAC? | There are no FDA approved drugs targeting the gene TRAC. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Medi-500, Tol-101, and Maslimomab. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%TRAC %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1483', 'drugName': 'Medi-500', 'newLinkedTargets_string': 'TRAV29DV5 (ENSG00000211810), TRAC (ENSG00000277734), TRBV7-9 (ENSG00000278030), TRGV3 (ENSG00000211699)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 3}, {'UUID': 'DrugGeneTargets_v2_5971', 'drugName': 'Tol-101', 'newLinkedTa... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1115 | Q4 | What drugs target the gene PPARG? | The drugs that target PPARG are Pioglitazone Hydrochloride, Pioglitazone, Balsalazide, Troglitazone, Balsalazide Disodium, Bezafibrate, Olsalazine Sodium, Olsalazine, Rosiglitazone Maleate, Mesalamine, and Rosiglitazone. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PPARG %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6144', 'drugName': 'Rosiglitazone', 'newLinkedTargets_string': 'PPARG (ENSG00000132170)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_1564', 'drugName': 'Bezafibrate', 'newLinkedTargets_string': 'PPARG (ENSG00000132170), PPARA (ENSG00000186951), PPARD ... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.705 | Q4 | What drugs target the gene IL6ST? | The drug that targets IL6ST is Satralizumab. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%IL6ST %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5618', 'drugName': 'Satralizumab', 'newLinkedTargets_string': 'IL6R (ENSG00000160712), IL6ST (ENSG00000134352)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.912 | Q4 | What drugs target the gene MT-ND4L? | The drugs that target MT-ND4L are Metformin and Metformin Hydrochloride. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%MT-ND4L %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1888', 'drugName': 'Metformin Hydrochloride', 'newLinkedTargets_string': 'GPD2 (ENSG00000115159), MT-ND6 (ENSG00000198695), NDUFA10 (ENSG00000130414), NDUFS8 (ENSG00000110717), MT-ND4L (ENSG00000212907), NDUFA6 (ENSG00000184983), MT-ND1 (ENSG00000198888), NDUFB6 (ENSG00000165264), NDUFA4 (... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1145 | Q4 | What drugs target the gene PRKDC? | There are no approved drugs targeting PRKDC, but the drug Cc-115, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PRKDC %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3410', 'drugName': 'Cc-115', 'newLinkedTargets_string': 'PRKDC (ENSG00000253729), MTOR (ENSG00000198793)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_3411', 'drugName': 'Cc-115', 'newLinkedTargets_string': 'PRKDC (ENSG00000253729), MTOR (ENSG00000198... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.256 | Q4 | What drugs target the gene CHEK1? | There are no FDA approved drugs targeting the gene CHEK1. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Prexasertib, Azd-7762, Rabusertib, Xl-844, Ly-2606368, Rg-7741, Sch-900776, Rg-7602, Ucn-01, and Pf-00477736. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%CHEK1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1309', 'drugName': 'Rabusertib', 'newLinkedTargets_string': 'CHEK1 (ENSG00000149554)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_4663', 'drugName': 'Ucn-01', 'newLinkedTargets_string': 'PDPK1 (ENSG00000140992), CDK2 (ENSG00000123374), CDK4 (ENSG0000... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.324 | Q4 | What drugs target the gene CSF3R? | The drugs that target CSF3R are Eflapegrastim, Lenograstim, Pegfilgrastim, Lipegfilgrastim, and Filgrastim. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%CSF3R %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4194', 'drugName': 'Pegfilgrastim', 'newLinkedTargets_string': 'CSF3R (ENSG00000119535)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_131', 'drugName': 'Eflapegrastim', 'newLinkedTargets_string': 'CSF3R (ENSG00000119535)', 'drugIsApproved': True, 'maxC... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1119 | Q4 | What drugs target the gene PPP2CB? | There are no approved drugs targeting PPP2CB, but the drug Lb-100, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PPP2CB %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4335', 'drugName': 'Lb-100', 'newLinkedTargets_string': 'PPP2CA (ENSG00000113575), PPP5C (ENSG00000011485), PPP2CB (ENSG00000104695)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_4336', 'drugName': 'Lb-100', 'newLinkedTargets_string': 'PPP2CA (ENSG000... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.428 | Q4 | What drugs target the gene EREG? | There are no approved drugs targeting EREG, but the drug Fepixnebart, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%EREG %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_509', 'drugName': 'Fepixnebart', 'newLinkedTargets_string': 'TGFA (ENSG00000163235), EREG (ENSG00000124882)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_510', 'drugName': 'Fepixnebart', 'newLinkedTargets_string': 'TGFA (ENSG00000163235), EREG (ENSG00... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.605 | Q4 | What drugs target the gene HRH4? | There are no FDA approved drugs targeting the gene HRH4. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Adriforant, Ur-63325, and Toreforant. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%HRH4 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1729', 'drugName': 'Adriforant', 'newLinkedTargets_string': 'HRH4 (ENSG00000134489)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_3852', 'drugName': 'Toreforant', 'newLinkedTargets_string': 'HRH4 (ENSG00000134489)', 'drugIsApproved': False, 'maxClinic... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1251 | Q4 | What drugs target the gene RPL3? | The drug that targets RPL3 is Ataluren. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%RPL3 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3776', 'drugName': 'Ataluren', 'newLinkedTargets_string': 'RPSA (ENSG00000168028), RPS27 (ENSG00000177954), RPS6 (ENSG00000137154), RPS2 (ENSG00000140988), RPS3 (ENSG00000149273), RPS3A (ENSG00000145425), RPS4X (ENSG00000198034), RPS4Y1 (ENSG00000129824), RPS5 (ENSG00000083845), RPS7 (ENSG... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.869 | Q4 | What drugs target the gene MASP2? | There are no approved drugs targeting MASP2, but the drug Narsoplimab, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%MASP2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2033', 'drugName': 'Narsoplimab', 'newLinkedTargets_string': 'MASP2 (ENSG00000009724)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 3}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.355 | Q4 | What drugs target the gene DDB1? | The drugs that target DDB1 are Thalidomide, Lenalidomide, and Pomalidomide. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%DDB1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_64', 'drugName': 'Thalidomide', 'newLinkedTargets_string': 'CRBN (ENSG00000113851), DDB1 (ENSG00000167986), CUL4A (ENSG00000139842), RBX1 (ENSG00000100387)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_4886', 'drugName': 'Pomalidomide', 'newLinkedTarge... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.719 | Q4 | What drugs target the gene ITGAL? | The drugs that target ITGAL are Lifitegrast and Efalizumab. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%ITGAL %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2931', 'drugName': 'Lifitegrast', 'newLinkedTargets_string': 'ITGAL (ENSG00000005844), ITGB2 (ENSG00000160255)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_5558', 'drugName': 'Efalizumab', 'newLinkedTargets_string': 'ITGAL (ENSG00000005844), ITGB2 (EN... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.88 | Q4 | What drugs target the gene ATP2A2? | There are no FDA approved drugs targeting the gene ATP2A2. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Mipsagargin and Istaroxime. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%ATP2A2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3997', 'drugName': 'Mipsagargin', 'newLinkedTargets_string': 'ATP2A3 (ENSG00000074370), ATP2A1 (ENSG00000196296), ATP2A2 (ENSG00000174437)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_4199', 'drugName': 'Istaroxime', 'newLinkedTargets_string': 'ATP1A... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1457 | Q4 | What drugs target the gene TNFSF14? | There are no FDA approved drugs targeting the gene TNFSF14. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Quisovalimab and Baminercept. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%TNFSF14 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_243', 'drugName': 'Quisovalimab', 'newLinkedTargets_string': 'TNFSF14 (ENSG00000125735)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_5474', 'drugName': 'Baminercept', 'newLinkedTargets_string': 'LTA (ENSG00000226979), LTB (ENSG00000227507), TNFSF14 (... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.267 | Q4 | What drugs target the gene CHRNA4? | The drugs that target CHRNA4 are Varenicline Tartrate, Nicotine, Varenicline, and Nicotine Polacrilex. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%CHRNA4 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2697', 'drugName': 'Varenicline', 'newLinkedTargets_string': 'CHRNB2 (ENSG00000160716), CHRNA4 (ENSG00000101204)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_2698', 'drugName': 'Varenicline', 'newLinkedTargets_string': 'CHRNB2 (ENSG00000160716), CHRNA... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.289 | Q4 | What drugs target the gene COL1A1? | The drugs that target COL1A1 are Collagenase Clostridium Histolyticum and Ocriplasmin. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%COL1A1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5818', 'drugName': 'Ocriplasmin', 'newLinkedTargets_string': 'FN1 (ENSG00000115414), COL1A2 (ENSG00000164692), COL1A1 (ENSG00000108821), COL2A1 (ENSG00000139219), COL3A1 (ENSG00000168542), COL4A1 (ENSG00000187498), COL5A1 (ENSG00000130635), COL6A1 (ENSG00000142156), COL11A1 (ENSG0000006071... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1522 | Q4 | What drugs target the gene UTS2R? | There are no approved drugs targeting UTS2R, but the drug Palosuran, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%UTS2R %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3294', 'drugName': 'Palosuran', 'newLinkedTargets_string': 'UTS2R (ENSG00000181408)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1180 | Q4 | What drugs target the gene PSMD14? | The drugs that target PSMD14 are Bortezomib, Carfilzomib, Ixazomib, and Ixazomib Citrate. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PSMD14 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_559', 'drugName': 'Bortezomib', 'newLinkedTargets_string': 'PSMD1 (ENSG00000173692), PSMB2 (ENSG00000126067), PSMB1 (ENSG00000008018), PSMB5 (ENSG00000100804), PSMB8 (ENSG00000204264), PSMB9 (ENSG00000240065), PSMB6 (ENSG00000142507), PSMD14 (ENSG00000115233), PSMA1 (ENSG00000129084), PSMA... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1168 | Q4 | What drugs target the gene PSMB8? | The drugs that target PSMB8 are Bortezomib, Carfilzomib, Ixazomib, and Ixazomib Citrate. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PSMB8 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3334', 'drugName': 'Ixazomib', 'newLinkedTargets_string': 'PSMD1 (ENSG00000173692), PSMB2 (ENSG00000126067), PSMB1 (ENSG00000008018), PSMB5 (ENSG00000100804), PSMB8 (ENSG00000204264), PSMB9 (ENSG00000240065), PSMB6 (ENSG00000142507), PSMD14 (ENSG00000115233), PSMA1 (ENSG00000129084), PSMA2... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.551 | Q4 | What drugs target the gene GRIN2C? | The drugs that target GRIN2C are Orphenadrine, Acamprosate Calcium, Felbamate, Amantadine Hydrochloride, Esketamine Hydrochloride, Acamprosate, Ketamine Hydrochloride, Memantine, Ketamine, Amantadine, Orphenadrine Hydrochloride, Esketamine, Memantine Hydrochloride, and Orphenadrine Citrate. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%GRIN2C %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6209', 'drugName': 'Orphenadrine Citrate', 'newLinkedTargets_string': 'GRIN1 (ENSG00000176884), GRIN2A (ENSG00000183454), GRIN2B (ENSG00000273079), GRIN2D (ENSG00000105464), GRIN3B (ENSG00000116032), GRIN2C (ENSG00000161509), GRIN3A (ENSG00000198785), HRH1 (ENSG00000196639), SLC6A2 (ENSG00... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1496 | Q4 | What drugs target the gene TUBA1C? | The drugs that target TUBA1C are Polatuzumab Vedotin, Cabazitaxel, Vinflunine, Brentuximab Vedotin, Docetaxel, Belantamab Mafodotin, Paclitaxel, Vinorelbine, Ixabepilone, Enfortumab Vedotin, Eribulin Mesylate, Vincristine Sulfate, Tisotumab Vedotin, Vinblastine, Colchicine, Vincristine, Eribulin, Trastuzumab Emtansine,... | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%TUBA1C %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3175', 'drugName': 'Eribulin Mesylate', 'newLinkedTargets_string': 'TUBB4B (ENSG00000188229), TUBB1 (ENSG00000101162), TUBA3C (ENSG00000198033), TUBA4A (ENSG00000127824), TUBB3 (ENSG00000258947), TUBA1A (ENSG00000167552), TUBB4A (ENSG00000104833), TUBB8 (ENSG00000261456), TUBB (ENSG0000019... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1005 | Q4 | What drugs target the gene NR1H2? | There are no FDA approved drugs targeting the gene NR1H2. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Cs-8080, Bms-852927, Rovazolac, Bms-779788, Lxr-623, Abequolixron, and Hyodeoxycholic_Acid. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%NR1H2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_132', 'drugName': 'Rovazolac', 'newLinkedTargets_string': 'NR1H3 (ENSG00000025434), NR1H2 (ENSG00000131408)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_5951', 'drugName': 'Hyodeoxycholic_Acid', 'newLinkedTargets_string': 'NR1H3 (ENSG00000025434), NR... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.223 | Q4 | What drugs target the gene CD74? | There are no approved drugs targeting CD74, but the drug Milatuzumab, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%CD74 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1018', 'drugName': 'Milatuzumab', 'newLinkedTargets_string': 'CD74 (ENSG00000019582)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.115 | Q4 | What drugs target the gene BIRC5? | There are no FDA approved drugs targeting the gene BIRC5. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Gataparsen and Svn53-67/M57-Klh Peptide Vaccine. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%BIRC5 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3583', 'drugName': 'Gataparsen', 'newLinkedTargets_string': 'BIRC5 (ENSG00000089685)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_3713', 'drugName': 'Svn53-67/M57-Klh Peptide Vaccine', 'newLinkedTargets_string': 'BIRC5 (ENSG00000089685)', 'drugIsAppr... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.592 | Q4 | What drugs target the gene HLA-DRB1? | There are no FDA approved drugs targeting the gene HLA-DRB1. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Apolizumab, Lym-1, and Plovamer Acetate. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%HLA-DRB1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4783', 'drugName': 'Lym-1', 'newLinkedTargets_string': 'HLA-DRB1 (ENSG00000196126)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 3}, {'UUID': 'DrugGeneTargets_v2_5057', 'drugName': 'Plovamer Acetate', 'newLinkedTargets_string': 'HLA-DRB1 (ENSG00000196126)', 'drugIsApproved': False, '... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.603 | Q4 | What drugs target the gene HRH2? | The drugs that target HRH2 are Cimetidine, Ranitidine Hydrochloride, Betazole, Tolazoline Hydrochloride, Nizatidine, Tolazoline, Methantheline, Betazole Hydrochloride, Methantheline Bromide, Ranitidine Bismuth Citrate, Ranitidine, Ebrotidine, Cimetidine Hydrochloride, and Famotidine. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%HRH2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6207', 'drugName': 'Famotidine', 'newLinkedTargets_string': 'HRH2 (ENSG00000113749)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_4211', 'drugName': 'Ranitidine', 'newLinkedTargets_string': 'HRH2 (ENSG00000113749)', 'drugIsApproved': True, 'maxClinical... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.176 | Q4 | What drugs target the gene CASP14? | There are no approved drugs targeting CASP14, but the drug Emricasan, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%CASP14 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_45', 'drugName': 'Emricasan', 'newLinkedTargets_string': 'CASP4 (ENSG00000196954), CASP9 (ENSG00000132906), CASP3 (ENSG00000164305), CASP5 (ENSG00000137757), CASP6 (ENSG00000138794), CASP7 (ENSG00000165806), CASP8 (ENSG00000064012), CASP1 (ENSG00000137752), CASP2 (ENSG00000106144), CASP10 ... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.792 | Q4 | What drugs target the gene KIR2DL3? | There are no FDA approved drugs targeting the gene KIR2DL3. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Iph-2101 and Lirilumab. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%KIR2DL3 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4725', 'drugName': 'Iph-2101', 'newLinkedTargets_string': 'KIR2DL2 (ENSG00000275546), KIR2DL1 (ENSG00000125498), KIR2DL3 (ENSG00000243772)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_5180', 'drugName': 'Lirilumab', 'newLinkedTargets_string': 'KIR2DL... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.382 | Q4 | What drugs target the gene E2F5? | There are no FDA approved drugs targeting the gene E2F5. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Edifoligide and Edifoligide Sodium. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%E2F5 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4614', 'drugName': 'Edifoligide Sodium', 'newLinkedTargets_string': 'E2F1 (ENSG00000101412), E2F2 (ENSG00000007968), E2F3 (ENSG00000112242), E2F4 (ENSG00000205250), E2F5 (ENSG00000133740), E2F6 (ENSG00000169016), E2F7 (ENSG00000165891), E2F8 (ENSG00000129173)', 'drugIsApproved': False, 'ma... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1205 | Q4 | What drugs target the gene PTPRB? | There are no approved drugs targeting PTPRB, but the drug Razuprotafib, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PTPRB %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3104', 'drugName': 'Razuprotafib', 'newLinkedTargets_string': 'PTPRB (ENSG00000127329)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.19 | Q4 | What drugs target the gene ADAMTS5? | There are no approved drugs targeting ADAMTS5, but the drug Aldumastat, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%ADAMTS5 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3081', 'drugName': 'Aldumastat', 'newLinkedTargets_string': 'ADAMTS5 (ENSG00000154736)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1012 | Q4 | What drugs target the gene NT5E? | There are no approved drugs targeting NT5E, but the drug Oleclumab, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%NT5E %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3999', 'drugName': 'Oleclumab', 'newLinkedTargets_string': 'NT5E (ENSG00000135318)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 3}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.287 | Q4 | What drugs target the gene COL15A1? | The drugs that target COL15A1 are Collagenase Clostridium Histolyticum and Ocriplasmin. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%COL15A1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5818', 'drugName': 'Ocriplasmin', 'newLinkedTargets_string': 'FN1 (ENSG00000115414), COL1A2 (ENSG00000164692), COL1A1 (ENSG00000108821), COL2A1 (ENSG00000139219), COL3A1 (ENSG00000168542), COL4A1 (ENSG00000187498), COL5A1 (ENSG00000130635), COL6A1 (ENSG00000142156), COL11A1 (ENSG0000006071... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1109 | Q4 | What drugs target the gene POLR1A? | There are no approved drugs targeting POLR1A, but the drug Tas-106, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%POLR1A %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3830', 'drugName': 'Tas-106', 'newLinkedTargets_string': 'POLR1A (ENSG00000068654), POLR3A (ENSG00000148606), POLR2A (ENSG00000181222)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_3831', 'drugName': 'Tas-106', 'newLinkedTargets_string': 'POLR1A (ENSG... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1308 | Q4 | What drugs target the gene RPS7? | The drug that targets RPS7 is Ataluren. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%RPS7 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3776', 'drugName': 'Ataluren', 'newLinkedTargets_string': 'RPSA (ENSG00000168028), RPS27 (ENSG00000177954), RPS6 (ENSG00000137154), RPS2 (ENSG00000140988), RPS3 (ENSG00000149273), RPS3A (ENSG00000145425), RPS4X (ENSG00000198034), RPS4Y1 (ENSG00000129824), RPS5 (ENSG00000083845), RPS7 (ENSG... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1226 | Q4 | What drugs target the gene RORC? | There are no approved drugs targeting RORC, but the drug Jte-151, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%RORC %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5616', 'drugName': 'Jte-151', 'newLinkedTargets_string': 'RORC (ENSG00000143365)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 1}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.32 | Q4 | What drugs target the gene ADRA1A? | The drugs that target ADRA1A are Methoxamine, Oxymetazoline, Dapiprazole Hydrochloride, Naphazoline Hydrochloride, Oxymetazoline Hydrochloride, Tetrahydrozoline, Silodosin, Trimipramine Maleate, Terazosin, Moxisylyte, Dipivefrin, Epinephrine, Carvedilol Phosphate, Doxazosin Mesylate, Tamsulosin, Methoxamine Hydrochlori... | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%ADRA1A %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_322', 'drugName': 'Dapiprazole Hydrochloride', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_1256', 'drugName': 'Terazosin Hydrochloride', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907), ADRA1D... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.570 | Q4 | What drugs target the gene HAVCR2? | There are no FDA approved drugs targeting the gene HAVCR2. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Ro-7121661, Sabatolimab, and Cobolimab. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%HAVCR2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2775', 'drugName': 'Sabatolimab', 'newLinkedTargets_string': 'HAVCR2 (ENSG00000135077)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 3}, {'UUID': 'DrugGeneTargets_v2_1538', 'drugName': 'Ro-7121661', 'newLinkedTargets_string': 'HAVCR2 (ENSG00000135077), PDCD1 (ENSG00000188389)', 'drug... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.212 | Q4 | What drugs target the gene CD3E? | The drugs that target CD3E are Catumaxomab, Muromonab-Cd3, Blinatumomab, and Teclistamab. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%CD3E %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6103', 'drugName': 'Teclistamab', 'newLinkedTargets_string': 'CD3E (ENSG00000198851), CD3G (ENSG00000160654), CD3D (ENSG00000167286), TNFRSF17 (ENSG00000048462)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_3214', 'drugName': 'Muromonab-Cd3', 'newLinke... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.999 | Q4 | What drugs target the gene NPR2? | The drug that targets NPR2 is Vosoritide. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%NPR2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6124', 'drugName': 'Vosoritide', 'newLinkedTargets_string': 'NPR2 (ENSG00000159899)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_2532', 'drugName': 'Carperitide', 'newLinkedTargets_string': 'NPR2 (ENSG00000159899), NPR1 (ENSG00000169418), NPR3 (ENSG00... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1504 | Q4 | What drugs target the gene TUBB3? | The drugs that target TUBB3 are Polatuzumab Vedotin, Cabazitaxel, Vinflunine, Brentuximab Vedotin, Docetaxel, Belantamab Mafodotin, Paclitaxel, Vinorelbine, Ixabepilone, Enfortumab Vedotin, Eribulin Mesylate, Vincristine Sulfate, Tisotumab Vedotin, Vinblastine, Colchicine, Vincristine, Eribulin, Trastuzumab Emtansine, ... | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%TUBB3 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1084', 'drugName': 'Brentuximab Vedotin', 'newLinkedTargets_string': 'TNFRSF8 (ENSG00000120949), TUBB4B (ENSG00000188229), TUBB1 (ENSG00000101162), TUBA3C (ENSG00000198033), TUBA4A (ENSG00000127824), TUBB3 (ENSG00000258947), TUBA1A (ENSG00000167552), TUBB4A (ENSG00000104833), TUBB8 (ENSG00... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1492 | Q4 | What drugs target the gene TTK? | There are no FDA approved drugs targeting the gene TTK. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Bay-1161909 and Bay-1217389. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%TTK %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_596', 'drugName': 'Bay-1161909', 'newLinkedTargets_string': 'TTK (ENSG00000112742)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 1}, {'UUID': 'DrugGeneTargets_v2_1430', 'drugName': 'Bay-1217389', 'newLinkedTargets_string': 'TTK (ENSG00000112742)', 'drugIsApproved': False, 'maxClinica... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.761 | Q4 | What drugs target the gene KCNH7? | The drugs that target KCNH7 are Dalfampridine, Guanidine, Amifampridine Phosphate, Guanidine Hydrochloride, and Amifampridine. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%KCNH7 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5118', 'drugName': 'Guanidine Hydrochloride', 'newLinkedTargets_string': 'KCNQ1 (ENSG00000053918), KCND3 (ENSG00000171385), KCNH2 (ENSG00000055118), KCNA2 (ENSG00000177301), KCNA1 (ENSG00000111262), KCNQ2 (ENSG00000075043), KCNQ3 (ENSG00000184156), KCNA7 (ENSG00000104848), KCNQ5 (ENSG00000... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1080 | Q4 | What drugs target the gene PIK3R2? | There are no FDA approved drugs targeting the gene PIK3R2. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Bgt-226, Pictilisib, Zstk-474, Azd-6482, Gsk-1059615, Paxalisib, Sf-1126, Sonolisib, Samotolisib, Panulisib, Voxtalisib, Wx-037, Pf-04691502, Bupar... | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PIK3R2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5563', 'drugName': 'Dactolisib', 'newLinkedTargets_string': 'PIK3R1 (ENSG00000145675), PIK3CB (ENSG00000051382), PIK3CG (ENSG00000105851), PIK3CA (ENSG00000121879), PIK3R2 (ENSG00000105647), PIK3CD (ENSG00000171608), PIK3R5 (ENSG00000141506), PIK3R3 (ENSG00000117461), MTOR (ENSG00000198793... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.872 | Q4 | What drugs target the gene MC3R? | There are no approved drugs targeting MC3R, but the drug Modimelanotide, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%MC3R %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2087', 'drugName': 'Modimelanotide', 'newLinkedTargets_string': 'MC3R (ENSG00000124089), MC1R (ENSG00000258839)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_2088', 'drugName': 'Modimelanotide', 'newLinkedTargets_string': 'MC3R (ENSG00000124089), MC1R... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.488 | Q4 | What drugs target the gene FZD7? | There are no approved drugs targeting FZD7, but the drug Vantictumab, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%FZD7 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5828', 'drugName': 'Vantictumab', 'newLinkedTargets_string': 'FZD2 (ENSG00000180340), FZD7 (ENSG00000155760), FZD1 (ENSG00000157240), FZD5 (ENSG00000163251), FZD8 (ENSG00000177283)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 1}, {'UUID': 'DrugGeneTargets_v2_5825', 'drugName': 'Vant... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.190 | Q4 | What drugs target the gene CCL2? | There are no approved drugs targeting CCL2, but the drug Carlumab, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%CCL2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1924', 'drugName': 'Carlumab', 'newLinkedTargets_string': 'CCL2 (ENSG00000108691)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.434 | Q4 | What drugs target the gene F10? | The drugs that target F10 are Rivaroxaban, Emicizumab, Antithrombin Alfa, Edoxaban, Apixaban, Edoxaban Tosylate, Betrixaban, and Coagulation Factor X Human. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%F10 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2886', 'drugName': 'Antithrombin Alfa', 'newLinkedTargets_string': 'F10 (ENSG00000126218), F2 (ENSG00000180210)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_5169', 'drugName': 'Betrixaban', 'newLinkedTargets_string': 'F10 (ENSG00000126218)', 'drugIsAp... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1404 | Q4 | What drugs target the gene STING1? | There are no approved drugs targeting STING1, but the drug Adu-S100, which potentially targets this gene, is currently undergoing clinical trials. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%STING1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4577', 'drugName': 'Adu-S100', 'newLinkedTargets_string': 'STING1 (ENSG00000184584)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}] | general | Select, Similarity Search, Order By | Genetic Target |
Q4.624 | Q4 | What drugs target the gene HTR3B? | The drugs that target HTR3B are Zimeldine, Amisulpride, Clothiapine, Dexfenfluramine, Tropisetron, Dexfenfluramine Hydrochloride, and Zimeldine Hydrochloride. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%HTR3B %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3083', 'drugName': 'Tropisetron', 'newLinkedTargets_string': 'HTR3A (ENSG00000166736), HTR3E (ENSG00000186038), HTR3B (ENSG00000149305), HTR3D (ENSG00000186090), HTR3C (ENSG00000178084)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_2388', 'drugName': '... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1196 | Q4 | What drugs target the gene PTGIR? | The drugs that target PTGIR are Epoprostenol Sodium, Iloprost, Treprostinil, Treprostinil Diolamine, Epoprostenol, and Selexipag. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PTGIR %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2582', 'drugName': 'Epoprostenol', 'newLinkedTargets_string': 'PTGIR (ENSG00000160013)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_1500', 'drugName': 'Epoprostenol Sodium', 'newLinkedTargets_string': 'PTGIR (ENSG00000160013)', 'drugIsApproved': True,... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.748 | Q4 | What drugs target the gene KCND2? | The drugs that target KCND2 are Dalfampridine, Guanidine, Amifampridine Phosphate, Guanidine Hydrochloride, and Amifampridine. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%KCND2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5118', 'drugName': 'Guanidine Hydrochloride', 'newLinkedTargets_string': 'KCNQ1 (ENSG00000053918), KCND3 (ENSG00000171385), KCNH2 (ENSG00000055118), KCNA2 (ENSG00000177301), KCNA1 (ENSG00000111262), KCNQ2 (ENSG00000075043), KCNQ3 (ENSG00000184156), KCNA7 (ENSG00000104848), KCNQ5 (ENSG00000... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.930 | Q4 | What drugs target the gene NAMPT? | There are no FDA approved drugs targeting the gene NAMPT. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Teglarinad, Daporinad, and Teglarinad Chloride. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%NAMPT %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1461', 'drugName': 'Daporinad', 'newLinkedTargets_string': 'NAMPT (ENSG00000105835)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 2}, {'UUID': 'DrugGeneTargets_v2_921', 'drugName': 'Teglarinad', 'newLinkedTargets_string': 'NAMPT (ENSG00000105835)', 'drugIsApproved': False, 'maxClinic... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.85 | Q4 | What drugs target the gene ATP1B2? | The drugs that target ATP1B2 are Acetyldigitoxin, Deslanoside, Digoxin, Lanatoside C, and Digitoxin. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%ATP1B2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2499', 'drugName': 'Digoxin', 'newLinkedTargets_string': 'ATP1A1 (ENSG00000163399), ATP1B2 (ENSG00000129244), ATP1B1 (ENSG00000143153), ATP1A2 (ENSG00000018625), ATP1B3 (ENSG00000069849), ATP1A3 (ENSG00000105409), ATP1A4 (ENSG00000132681), FXYD2 (ENSG00000137731)', 'drugIsApproved': True, ... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1079 | Q4 | What drugs target the gene PIK3R1? | There are no FDA approved drugs targeting the gene PIK3R1. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Bgt-226, Pictilisib, Zstk-474, Azd-6482, Gsk-1059615, Paxalisib, Sf-1126, Sonolisib, Samotolisib, Panulisib, Voxtalisib, Wx-037, Pf-04691502, Bupar... | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PIK3R1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5563', 'drugName': 'Dactolisib', 'newLinkedTargets_string': 'PIK3R1 (ENSG00000145675), PIK3CB (ENSG00000051382), PIK3CG (ENSG00000105851), PIK3CA (ENSG00000121879), PIK3R2 (ENSG00000105647), PIK3CD (ENSG00000171608), PIK3R5 (ENSG00000141506), PIK3R3 (ENSG00000117461), MTOR (ENSG00000198793... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.49 | Q4 | What drugs target the gene AKT1? | There are no FDA approved drugs targeting the gene AKT1. However, the following drugs, which potentially target this gene, are currently in various clinical trial stages: Miransertib, Bay-1125976, Triciribine Phosphate, Mk-2201, Gsk-690693, Sr-13668, Xl-418, Afuresertib, Uprosertib, Msc-2363318A, Mk-2206, Ipatasertib, ... | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%AKT1 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6037', 'drugName': 'Capivasertib', 'newLinkedTargets_string': 'AKT2 (ENSG00000105221), AKT3 (ENSG00000117020), AKT1 (ENSG00000142208)', 'drugIsApproved': False, 'maxClinicalTrialPhase': 3}, {'UUID': 'DrugGeneTargets_v2_2935', 'drugName': 'Ipatasertib', 'newLinkedTargets_string': 'AKT2 (ENS... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.1141 | Q4 | What drugs target the gene PRKCQ? | The drug that targets PRKCQ is Midostaurin. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%PRKCQ %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5666', 'drugName': 'Midostaurin', 'newLinkedTargets_string': 'KIT (ENSG00000157404), KDR (ENSG00000128052), PDGFRB (ENSG00000113721), PDGFRA (ENSG00000134853), FLT3 (ENSG00000122025), PRKD3 (ENSG00000115825), PRKCI (ENSG00000163558), PRKCA (ENSG00000154229), PRKCG (ENSG00000126583), PRKCD ... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.157 | Q4 | What drugs target the gene CACNB2? | The drugs that target CACNB2 are Gabapentin, Terodiline Hydrochloride, Phloroglucinol, Suloctidil, Pregabalin, Gabapentin Enacarbil, Bepridil Hydrochloride, Bepridil, and Terodiline. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%CACNB2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_142', 'drugName': 'Gabapentin', 'newLinkedTargets_string': 'CACNA1H (ENSG00000196557), CACNA2D1 (ENSG00000153956), CACNA1C (ENSG00000151067), CACNA2D3 (ENSG00000157445), CACNA1S (ENSG00000081248), CACNA2D2 (ENSG00000007402), CACNA1D (ENSG00000157388), CACNA1A (ENSG00000141837), CACNA1B (EN... | general | Select, Similarity Search, Order By | Genetic Target |
Q4.723 | Q4 | What drugs target the gene ITGB2? | The drugs that target ITGB2 are Lifitegrast and Efalizumab. | SELECT DISTINCT UUID, drugName, newLinkedTargets_string, drugIsApproved, maxClinicalTrialPhase
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE newLinkedTargets_string LIKE '%ITGB2 %'
ORDER BY maxClinicalTrialPhase DESC
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5558', 'drugName': 'Efalizumab', 'newLinkedTargets_string': 'ITGAL (ENSG00000005844), ITGB2 (ENSG00000160255)', 'drugIsApproved': True, 'maxClinicalTrialPhase': 4}, {'UUID': 'DrugGeneTargets_v2_2931', 'drugName': 'Lifitegrast', 'newLinkedTargets_string': 'ITGAL (ENSG00000005844), ITGB2 (EN... | general | Select, Similarity Search, Order By | Genetic Target |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.